To investigate the regulation of Graptopetalun paraguayense in TGF-β pathway and lipogenesis in HCC via gene expression signature
碩士 === 國立陽明大學 === 生物藥學研究所 === 102 === Hepatocellular carcinoma (HCC) is an aggressive tumor with a poor prognosis and most common cause of cancer deaths in the world. However, sorafenib is the only target therapy of HCC approved by the FDA and prolongs patient’s survival for 2-3 months. Therefore, i...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2013
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/rwzytc |